Repurposing Anti-Viral Subunit and mRNA Vaccines T Cell Immunity for Intratumoral Immunotherapy against Solid Tumors

Scientists demonstrated the potential of licensed vaccines as promising platforms for intratumoral immunotherapy, either alone or combined with vaccine- or tumor-derived MHC-I-restricted peptide epitopes.